YDES
YD Bio Ltd
Price Chart
Latest Quote
$11.47
Current Price| Previous Close | $11.87 |
| Open | $11.65 |
| Day High | $12.00 |
| Day Low | $11.30 |
| Volume | 26,974 |
Stock Information
| Shares Outstanding | 70.52M |
| Total Debt | $22K |
| Cash Equivalents | $3.13M |
| Revenue | $510K |
| Net Income | $-1.41M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $808.88M |
| EPS (TTM) | $-0.02 |
| Exchange | NGM |
đ Custom Metrics & Score
Score: 22/42| Debt to Equity | 0.00 |
| Debt to Earnings | 0.15 |
| Current Ratio | 13.18 |
| Quick Ratio | 12.91 |
| Avg Revenue Growth | 22.88% |
| Profit Margin | -276.58% |
| Return on Equity | -21.42% |
| Avg FCF Growth | 4193.13% |
| FCF Yield | -0.59% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $11.47 | 26,974 |
| 2026-01-30 | $11.87 | 35,000 |
| 2026-01-29 | $11.03 | 58,200 |
| 2026-01-28 | $12.24 | 13,300 |
| 2026-01-27 | $12.16 | 33,400 |
| 2026-01-26 | $12.02 | 18,100 |
| 2026-01-23 | $12.36 | 11,800 |
| 2026-01-22 | $12.30 | 62,000 |
| 2026-01-21 | $12.00 | 53,100 |
| 2026-01-20 | $11.95 | 80,000 |
| 2026-01-16 | $11.32 | 28,600 |
| 2026-01-15 | $11.42 | 94,600 |
| 2026-01-14 | $11.80 | 13,100 |
| 2026-01-13 | $11.82 | 17,300 |
| 2026-01-12 | $11.82 | 52,800 |
| 2026-01-09 | $12.34 | 58,700 |
| 2026-01-08 | $12.33 | 116,300 |
| 2026-01-07 | $11.50 | 115,700 |
| 2026-01-06 | $11.66 | 328,700 |
| 2026-01-05 | $12.68 | 70,500 |
About YD Bio Ltd
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Reconciled Cost Of Revenue | $355,004 | $196,686 |
| Cost Of Revenue | $355,004 | $196,686 |
| Total Revenue | $510,360 | $350,131 |
| Operating Revenue | $510,360 | $350,131 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Interest Expense | $772 | $2,144 |
| Total Expenses | $1,972,783 | $357,247 |
| Other Income Expense | $64,908 | $26,620 |
| Other Non Operating Income Expenses | $64,415 | $29,351 |
| Net Non Operating Interest Income Expense | $11,036 | $-1,854 |
| Interest Expense Non Operating | $772 | $2,144 |
| Operating Expense | $1,617,779 | $160,561 |
| Selling And Marketing Expense | $1,957 | $7,492 |
| General And Administrative Expense | $1,124,469 | $153,069 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-1,411,559 | $13,560 |
| Net Interest Income | $11,036 | $-1,854 |
| Interest Income | $11,808 | $290 |
| Normalized Income | $-1,411,953 | $15,658 |
| Net Income From Continuing And Discontinued Operation | $-1,411,559 | $13,560 |
| Total Operating Income As Reported | $-1,461,930 | $-9,847 |
| Net Income Common Stockholders | $-1,411,559 | $13,560 |
| Net Income | $-1,411,559 | $13,560 |
| Net Income Including Noncontrolling Interests | $-1,411,559 | $13,560 |
| Net Income Continuous Operations | $-1,411,559 | $13,560 |
| Pretax Income | $-1,386,479 | $17,650 |
| Special Income Charges | $493 | $-2,731 |
| Interest Income Non Operating | $11,808 | $290 |
| Operating Income | $-1,462,423 | $-7,116 |
| Gross Profit | $155,356 | $153,445 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Diluted EPS | - | $0.00 |
| Basic EPS | - | $0.00 |
Other
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Tax Effect Of Unusual Items | $99 | $-633 |
| Tax Rate For Calcs | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-1,281,465 | $24,977 |
| Total Unusual Items | $493 | $-2,731 |
| Total Unusual Items Excluding Goodwill | $493 | $-2,731 |
| Reconciled Depreciation | $104,735 | $2,452 |
| EBITDA (Bullshit earnings) | $-1,280,972 | $22,246 |
| EBIT | $-1,385,707 | $19,794 |
| Diluted NI Availto Com Stockholders | $-1,411,559 | $13,560 |
| Tax Provision | $25,080 | $4,090 |
| Write Off | $-493 | $2,731 |
| Research And Development | $491,353 | $0 |
| Selling General And Administration | $1,126,426 | $160,561 |
| Other Gand A | $1,124,469 | $153,069 |
| Diluted Average Shares | - | $70,095,411 |
| Basic Average Shares | - | $70,095,411 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Net Tangible Assets | $3,910,211 | $22,994 |
| Total Assets | $6,864,226 | $321,212 |
| Total Non Current Assets | $3,396,344 | $49,488 |
| Non Current Deferred Assets | $628,232 | $24,565 |
| Non Current Deferred Taxes Assets | $0 | $24,565 |
| Investmentin Financial Assets | $0 | $10,618 |
| Goodwill And Other Intangible Assets | $2,680,035 | $0 |
| Other Intangible Assets | $2,680,035 | - |
| Current Assets | $3,467,882 | $271,724 |
| Prepaid Assets | $35,453 | $16,788 |
| Inventory | $37,335 | $69,404 |
| Receivables | $262,796 | $98,434 |
| Taxes Receivable | $159,287 | $267 |
| Notes Receivable | $16,927 | $0 |
| Accounts Receivable | $86,582 | $98,167 |
| Allowance For Doubtful Accounts Receivable | $-3,055 | $-3,769 |
| Gross Accounts Receivable | $89,637 | $101,936 |
| Cash Cash Equivalents And Short Term Investments | $3,132,298 | $87,098 |
| Cash And Cash Equivalents | $3,132,298 | $87,098 |
Debt
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Total Debt | $22,555 | $47,576 |
| Long Term Debt And Capital Lease Obligation | $5,684 | $0 |
| Current Debt And Capital Lease Obligation | $16,871 | $47,576 |
| Current Debt | $290 | $34,319 |
| Other Current Borrowings | - | $34,319 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Total Liabilities Net Minority Interest | $273,980 | $298,218 |
| Total Non Current Liabilities Net Minority Interest | $10,920 | $0 |
| Other Non Current Liabilities | $3,773 | - |
| Non Current Deferred Liabilities | $1,463 | - |
| Non Current Deferred Taxes Liabilities | $1,463 | - |
| Current Liabilities | $263,060 | $298,218 |
| Current Notes Payable | $290 | $0 |
| Payables And Accrued Expenses | $246,189 | $250,298 |
| Payables | $63,829 | $237,196 |
| Accounts Payable | $26,743 | $17,976 |
| Current Deferred Liabilities | - | $344 |
| Total Tax Payable | - | $1,969 |
Equity
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Common Stock Equity | $6,590,246 | $22,994 |
| Total Equity Gross Minority Interest | $6,590,246 | $22,994 |
| Stockholders Equity | $6,590,246 | $22,994 |
| Gains Losses Not Affecting Retained Earnings | $45,072 | $47,211 |
| Retained Earnings | $-1,927,043 | $-515,484 |
Other
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Ordinary Shares Number | $70,095,411 | $70,095,411 |
| Share Issued | $70,095,411 | $70,095,411 |
| Tangible Book Value | $3,910,211 | $22,994 |
| Invested Capital | $6,590,536 | $57,313 |
| Working Capital | $3,204,822 | $-26,494 |
| Capital Lease Obligations | $22,265 | $13,257 |
| Total Capitalization | $6,590,246 | $22,994 |
| Additional Paid In Capital | $8,328,040 | $386,067 |
| Capital Stock | $144,177 | $105,200 |
| Common Stock | $144,177 | $105,200 |
| Long Term Capital Lease Obligation | $5,684 | $0 |
| Current Capital Lease Obligation | $16,581 | $13,257 |
| Current Accrued Expenses | $182,360 | $13,102 |
| Dueto Related Parties Current | $37,086 | $217,251 |
| Investments And Advances | $0 | $10,618 |
| Net PPE | $88,077 | $14,305 |
| Accumulated Depreciation | $-17,431 | $-7,949 |
| Gross PPE | $105,508 | $22,254 |
| Machinery Furniture Equipment | $81,810 | $9,139 |
| Buildings And Improvements | $23,698 | $13,115 |
| Properties | $0 | $0 |
| Finished Goods | $37,335 | $69,404 |
| Current Deferred Revenue | - | $0 |
| Available For Sale Securities | - | $10,618 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Free Cash Flow | $-4,747,812 | $-55,947 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Operating Cash Flow | $-1,836,818 | $-55,657 |
| Cash Flow From Continuing Operating Activities | $-1,836,818 | $-55,657 |
| Operating Gains Losses | - | $466 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Capital Expenditure | $-2,910,994 | $-290 |
| Investing Cash Flow | $-2,900,670 | $-290 |
| Cash Flow From Continuing Investing Activities | $-2,900,670 | $-290 |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Issuance Of Capital Stock | $7,860,181 | $52,952 |
| Financing Cash Flow | $7,727,646 | $113,887 |
| Cash Flow From Continuing Financing Activities | $7,727,646 | $113,887 |
| Net Other Financing Charges | $-99,558 | $93,544 |
| Net Common Stock Issuance | $7,860,181 | $52,952 |
| Common Stock Issuance | $7,860,181 | $52,952 |
Other
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Repayment Of Debt | $-32,977 | $-32,609 |
| Interest Paid Supplemental Data | $772 | $2,144 |
| Income Tax Paid Supplemental Data | $0 | $0 |
| End Cash Position | $3,132,298 | $87,098 |
| Beginning Cash Position | $87,098 | $30,142 |
| Effect Of Exchange Rate Changes | $55,042 | $-984 |
| Changes In Cash | $2,990,158 | $57,940 |
| Net Issuance Payments Of Debt | $-32,977 | $-32,609 |
| Net Long Term Debt Issuance | $-32,977 | $-32,609 |
| Long Term Debt Payments | $-32,977 | $-32,609 |
| Net Investment Purchase And Sale | $10,324 | $0 |
| Sale Of Investment | $10,324 | $0 |
| Net Intangibles Purchase And Sale | $-2,836,080 | $0 |
| Purchase Of Intangibles | $-2,836,080 | $0 |
| Net PPE Purchase And Sale | $-74,914 | $-290 |
| Purchase Of PPE | $-74,914 | $-290 |
| Change In Working Capital | $-567,808 | $-126,696 |
| Change In Other Working Capital | $-614,137 | - |
| Change In Other Current Liabilities | $-12,239 | $-47,082 |
| Change In Payables And Accrued Expense | $223,791 | $9,996 |
| Change In Accrued Expense | $213,595 | $4,605 |
| Change In Payable | $10,196 | $5,391 |
| Change In Account Payable | $10,196 | $5,391 |
| Change In Prepaid Assets | $-182,721 | $4,818 |
| Change In Inventory | $28,517 | $-30,570 |
| Change In Receivables | $-11,019 | $-63,858 |
| Changes In Account Receivables | $6,297 | $-63,858 |
| Other Non Cash Items | $11,731 | $47,740 |
| Asset Impairment Charge | $-493 | $2,731 |
| Deferred Tax | $26,576 | $4,090 |
| Deferred Income Tax | $26,576 | $4,090 |
| Depreciation Amortization Depletion | $104,735 | $2,452 |
| Depreciation And Amortization | $104,735 | $2,452 |
| Amortization Cash Flow | $94,536 | $0 |
| Amortization Of Intangibles | $94,536 | $0 |
| Depreciation | $10,199 | $2,452 |
| Gain Loss On Sale Of PPE | $0 | $466 |
| Net Income From Continuing Operations | $-1,411,559 | $13,560 |